Showing results (91-100 of 179) with videos related to
Sort By:
Pageof 18
Neuropsychiatric Disease and Treatment|January 16, 2019
Differences in etiological beliefs about schizophrenia among patients, family, and medical staffNatsumi Tarakita, Kazutaka Yoshida, Norio Sugawara, et al.Therapeutic Drug Monitoring|November 25, 2020
Relationship of Prolactin Concentrations to Steady-State Plasma Concentrations of Aripiprazole in Patients With SchizophreniaMinami Tasaki, Norio Yasui-Furukori, Kazuyoshi Kubo, et al.Neuropsychiatric Disease and Treatment|February 5, 2021
Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT IntervalHiroaki Okayasu, Takahiro Shinozaki, Yumiko Takano, et al.BMC Psychiatry|June 21, 2014
Dietary patterns are associated with obesity in Japanese patients with schizophreniaNorio Sugawara, Norio Yasui-Furukori, Yasushi Sato, et al.Schizophrenia Research|October 22, 2017
Prevalence of underweight in patients with schizophrenia: A meta-analysisNorio Sugawara, Kazushi Maruo, Takuro Sugai, et al.BMC Psychiatry|April 11, 2013
Body mass index and quality of life among outpatients with schizophrenia in JapanNorio Sugawara, Norio Yasui-Furukori, Yasushi Sato, et al.Neuropsychiatric Disease and Treatment|December 18, 2020
The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical SymptomsNorio Sugawara, Norio Yasui-Furukori, Toshinaga Tsuji, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 23, 2010
Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophreniaNorio Yasui-Furukori, Manabu Saito, Taku Nakagami, et al.Psychiatry and Clinical Neurosciences|June 5, 2014
Sex-specific effects of subjective memory complaints with respect to cognitive impairment or depressive symptomsTetsu Tomita, Norio Sugawara, Ayako Kaneda, et al.Plos One|May 27, 2014
The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorderTetsu Tomita, Norio Yasui-Furukori, Taku Nakagami, et al.Pageof 18